Net Income

With its CEO out and finances under pressure, Spirit Blockchain Capital appoints its chairman to two interim roles, raising questions about its future.

New clinical consensus on ammonia and scrutiny of a standard antibiotic are creating a perfect storm for Yaqrit's promising new liver disease treatments.

With a deficit of 86,000 doctors looming, technology like AI is being touted as a key solution to save primary care from administrative overload.

Brunswick's Freedom Boat Club just bought its largest franchise, signaling a strategic consolidation and a major bet on the 'boating-as-a-service' model.

The 'Big Red Rebuild' aims to transform Memorial Stadium, promising a $1.1B economic boost without taxpayer funds. But can it balance legacy and profit?

At AACR 2026, CREATE Medicines debuts its RetroT platform, an all-RNA system for stable gene delivery that avoids viral vectors and reshapes cell therapy.

A gaming giant is pivoting to cultural patronage, using art and tech to redefine Macau's future beyond the casino floor. Here's how it's happening.

Preliminary Q1 data from Auna shows rising demand for specialized care in Peru, Colombia, and Mexico, offering investors a transparent new look.

With a $100M deal for UK's UDlive, Badger Meter is building a global powerhouse to tackle aging pipes, overflows, and climate change with smart tech.

Christopher Kilpatrick's 2026 departure from Western Asset's HIX fund is part of a larger strategic personnel shift at parent company Franklin Templeton.

Tacotarian and KLIMON team up at Las Vegas's Sick New World festival, proving that plant-based dining is the new, indulgent headliner for festival fare.

With the appointment of a new CTO, ChronicCareIQ signals a major push into AI to scale its platform and revolutionize chronic disease management.

The ACORYS® system offers a non-invasive, real-time, four-chamber heart view, promising to revolutionize arrhythmia treatment and challenge market leaders.

Biotech veteran Habib Dable, who led Acceleron to an $11.5B Merck sale, joins Tyra Biosciences' board, signaling a major push toward commercialization.

The aviation finance giant taps new capital pools with a dual-tranche facility, part of a $2.5B haul signaling aggressive growth and market confidence.

Byondis presents two novel ADC platforms at AACR 2026, aiming to solve drug resistance and offer hope for patients unresponsive to immunotherapy.

After two massive data breaches exposed millions, MGM offers Canadian victims a $4M settlement. Here's how to claim your share and what this case reveals.

With net profits soaring over 60% and a record order book, the industrial giant is aggressively pivoting toward green hydrogen, robotics, and global markets.

With HKD 255M in sales and major growth in modern art and jewels, Poly Auction's spring event shows renewed collector confidence in Hong Kong's market.

With a successful $191M IPO, Alamar Biosciences is set to revolutionize diagnostics with its ultra-sensitive proteomics platforms.